Dalcetrapib | search
Click here to view Dalcetrapib news from 60+ newspapers.
Bookmark or Share- Dalcetrapib: Uses, Interactions, Mechanism of Action - DrugBank OnlineDalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.
- Dalcetrapib History - DalCor PharmaceuticalsDalcetrapib is an investigational therapy that would potentially be the first pharmacogenomic precision medicine in cardiovascular disease to reduce cardiovascular risk. Dalcetrapib, while under development by Roche, was evaluated in a Phase 3, double- blind clinical trial, dal-OUTCOMES.
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary ...Dalcetrapib is a CETP inhibitor that raised HDL cholesterol levels by approximately 30% in phase 2 studies, without significant effects on LDL cholesterol levels, blood pressure, or circulating...
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary SyndromeWe randomly assigned 15,871 patients who had had a recent acute coronary syn-drome to receive the CETP inhibitor dalcetrapib, at a dose of 600 mg daily, or placebo, in addition to the best...
- Dalcetrapib by DalCor Pharmaceuticals for Coronavirus Disease 2019 ...Dalcetrapib acts by targeting cholesteryl ester transfer protein (CETP). Dalcetrapib increases the levels of high-density lipoprotein cholesterol (HDLC) thereby potentially reducing the risk of cardiovascular disease and death in high-risk patients. It is administered through the oral route. It was under development for the treatment of ...
More
